Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. (Q38461049)

From Wikidata

Jump to navigation Jump to search

scientific article published on 07 June 2012

Language	Label	Description	Also known as
English	Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.	scientific article published on 07 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

influenza A virus

object named as

influenza A virus

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Ho-Jin Moon

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Melbourne R Talactac

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Mohammed Y E Chowdhury

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Jae-Hoon Kim

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Min-Eun Park

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Young-Ki Choi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Moon-Hee Sung

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Chul-Joong Kim

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 June 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Veterinary Microbiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

160

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

277-289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

3-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22763171%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Multifunctional conjugation of proteins on/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Human T helper (Th) cell lineage commitment is not directly linked to the secretion of IFN-gamma or IL-4: characterization of Th cells isolated by FACS based on IFN-gamma and IL-4 secretion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Adjuvant synergy: the effects of nasal coadministration of adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

New biological functions and applications of high-molecular-mass poly-gamma-glutamic acid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Induction of heterosubtypic immunity to influenza virus by intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Chitosan and its derivatives as intestinal absorption enhancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

New generation of mucosal adjuvants for the induction of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.05.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38461049&oldid=2142288803"